<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:regsci-ojs-tamu.tdl.org:article/85</identifier>
				<datestamp>2023-04-11T00:18:09Z</datestamp>
				<setSpec>regsci:LE</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Reply to “Letter to the Editor: The Pathology Community's Interpretation of Settiagounder’s Proposals on GLP Process as Applied to Pathology Peer Review”</dc:title>
	<dc:creator xml:lang="en">Settiagounder, Natesan</dc:creator>
	<dc:description xml:lang="en">https://doi.org/10.21423/jrs-v06n01pxii (DOI assigned 1/24/2019)</dc:description>
	<dc:publisher xml:lang="en">Office of the Texas State Chemist</dc:publisher>
	<dc:date>2018-03-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://regsci-ojs-tamu.tdl.org/regsci/article/view/85</dc:identifier>
	<dc:identifier>10.21423/JRS-V06N01PXII</dc:identifier>
	<dc:source xml:lang="en">Journal of Regulatory Science; Vol 6, No 1 (2018); xii-xix</dc:source>
	<dc:source>2377-3537</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://regsci-ojs-tamu.tdl.org/regsci/article/view/85/82</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2018 Journal of Regulatory Science</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
